ABT
NYSE · Health Care
Abbott Laboratories
$102.67
+0.79 (+0.78%)
Analyst Consensus
Buy
35
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+20.3% upside
Low Target
$104.85
Average Target
$123.47
High Target
$190.33
Current Price
$102.67
Current
$102.67
$102.67
Target
$123.47
$123.47
$104.85
$123.47 avg
$190.33
Scenario Analysis
Bear Case
$104.85
2.1%
Low target
Base Case
$123.47
+20.3%
Avg target
Bull Case
$190.33
+85.4%
High target
Risk/Reward
40.2x
Highly favorable
Price in Context
52-Week High
$139.06
-26.2% from high
52-Week Low
$102.41
+0.3% from low
50-Day SMA
$118.82
-13.6% vs SMA
200-Day SMA
$127.91
-19.7% vs SMA
RSI (14)
69.3
Neutral
Target vs 52W High
$123.47
-11.2% vs high
Next Earnings Report
Apr 14, 2026 · Before Market Open
12d
until earnings
EPS Est: $1.16
Earnings in 12 days. Analyst targets may shift significantly after the report.
Peer Consensus — Health Care
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| UNH | Buy | 34 | 68% | $293.85 | +8.6% |
| ABT | Buy | 35 | 71% | $123.47 | +20.3% |
| ISRG | Buy | 42 | 69% | $219.77 | -52.3% |
| SYK | Strong Buy | 37 | 76% | $338.36 | +3.0% |
| MDT | Buy | 38 | 63% | $192.46 | +122.1% |
| HCA | Buy | 31 | 58% | $118.82 | -74.9% |
| MCK | Strong Buy | 22 | 86% | $307.39 | -64.5% |
| BSX | Strong Buy | 40 | 93% | $136.36 | +117.3% |